Janux Therapeutics, Inc. (JANX) Misses Q1 EPS by 1c

Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q1 EPS of ($0.38), $0.01 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.

You May Also Be Interested In

• Trump: Scott Bessent will not be going to be super intelligence (SI) czar
• Iran's President says Tehran agrees on need to return to Islamabad understanding, honor commitments
• Bessent: Discussed Desirability Of Strong Yen With Japan's FM